Ethypharm Digital Therapy (EDT) is a European Lifescience company, pioneered by entrepreneurial healthcare market specialists who put their passion into agile ways of redefining disease management. EDT’s mission is to offer personalised and clinically-proven digital therapies in an ethical manner. Founded in 2021, EDT hold the exclusive rights in France, UK, Italy and Spain for deprexis®, the first digital therapy for patients suffering from depression and looking for immediate and 24/7 accessibility to a psychotherapy . Ethypharm Digital Therapy SAS is fully-owned by the Ethypharm Group.